[HTML][HTML] Pharmacist's use of screening tools to estimate risk of CVD: a review of the literature

DO O'Donovan, S Byrne, LJ Sahm - Pharmacy, 2014 - mdpi.com
To review pharmacist-led screening programmes for estimation of cardiovascular disease
(CVD) risk using validated screening tools, studies were identified using a search of the …

Cardiovascular risk screening program in Australian community pharmacies

GM Peterson, KD Fitzmaurice, H Kruup… - Pharmacy world & …, 2010 - Springer
Objective To assess the suitability of Australian community pharmacies as cardiovascular
disease risk profile screening centres and evaluate whether community pharmacists can …

[HTML][HTML] Feasibility of cardiovascular risk screening in Portuguese community pharmacies

AA Fonseca, TM Lima, M Castel-Branco… - Pharmacy Practice …, 2021 - SciELO Espana
Resumen FONSECA, Anabela A; LIMA, Tácio M; CASTEL-BRANCO, Margarida y
FIGUEIREDO, Isabel V. Feasibility of cardiovascular risk screening in Portuguese …

A community pharmacy-based cardiovascular screening service: views of service users and the public

J Taylor, J Krska, A Mackridge - International Journal of …, 2012 - academic.oup.com
Objectives To determine whether pharmacy-based cardiovascular disease (CVD) screening
reached the desired population, the local population's awareness of pharmacy screening …

[HTML][HTML] Evaluation of a controlled, national collaboration study on a clinical pharmacy service of screening for risk medications

LJ Kjeldsen, MH Clemmensen, C Kronborg… - International journal of …, 2014 - Springer
Background Risk medications are frequently associated with adverse events and
hospitalisations. Objective To evaluate a risk medication screening service for in-patients at …

[HTML][HTML] A community pharmacy-based cardiovascular risk screening service implemented in Iran

Z Jahangard-Rafsanjani, N Hakimzadeh… - Pharmacy Practice …, 2017 - SciELO Espana
JAHANGARD-RAFSANJANI, Zahra et al. A community pharmacy-based cardiovascular risk
screening service implemented in Iran. Pharmacy Pract (Granada)[online]. 2017, vol. 15, n …

Screening for cardiovascular disease: concepts, conflicts, and consensus

JP Frolkis - Medical Clinics of North America, 1999 - Elsevier
Because the treatment of cardiovascular disease (CVD) constitutes such a large part of
primary care practice, the busy clinician can feel overwhelmed by advice from experts about …

Development and evaluation of an educational program for community pharmacists on cardiovascular risk assessment

M Zolezzi, O Abdallah… - Risk Management and …, 2020 - Taylor & Francis
Purpose Cardiovascular disease (CVD) risk assessment is an important strategy for the
prevention of CVD. Pharmacists play an important role in CVD risk assessment and …

[HTML][HTML] Evaluating the effectiveness of the cardiovascular assessment screening program with nurse practitioners and patients: results of a cluster randomised …

J Bruneau, D Moralejo, K Parsons - BMC Primary Care, 2024 - Springer
Background There is inconsistent utilisation of clinical practice guidelines (CPGs) for
cardiovascular disease (CVD) screening and management by healthcare professionals to …

[HTML][HTML] Development of the Cardiovascular Assessment Screening Program (CASP) using the qualitative findings of a mixed methods study and applying the TDF to …

J Bruneau, K Parsons, D Moralejo, C Donovan - BMC Primary Care, 2023 - Springer
Background There is inconsistent utilisation of clinical practice guidelines (CPGs) for
cardiovascular disease (CVD) screening and management by healthcare professionals to …